Skip to main content
Insights
What's trending
Highlights from our recent research
Report
Analysing global 2025 IFRS results
We examine the 2025 IFRS results from 107 (re)insurance companies worldwide, covering financial position, performance, value components, and value creation.
White paper
GLP-1 medications in the United States
We provide a practical overview of the current environment for weight-loss drugs, exploring coverage obligations, utilization management strategies, and cost dynamics.
White paper
How housing finance agencies can better measure performance, benchmark results, and prepare for emerging risks
We review key performance indicators, discuss why benchmarks matter, and offer thoughts on climate risk and portfolio resilience affecting state housing finance agencies.
Loading...